ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly long-lived assets — Europe ($M) [legacy grouping through FY2018] ($M)
Form 10-K Geographic Information Note
Latest, FY2018
2,708
Period ended Dec 31, 2018
Change on a year earlier
+6.2%
2,550 in FY2017
History
9 years
Since FY2010
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Long-lived assets — Europe ($M) [legacy grouping through FY2018] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2018 | Dec 31, 2018 | 2,708 | +6.2% | Form 10-K (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 2,550 | +19.1% | Form 10-K (filed 2019-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 2,141 | -7.2% | Form 10-K (filed 2019-02-19) ↗ |
| FY2015 | Dec 31, 2015 | 2,306 | -4.0% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 2,402 | -2.8% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 2,470 | +8.3% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 2,281 | +2.7% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 2,220 | -1.4% | Form 10-K (filed 2013-02-21) ↗ |
| FY2010 | Dec 31, 2010 | 2,251 | – | Form 10-K (filed 2013-02-21) ↗ |
Cite this data
StockData. (2026). Eli Lilly Long-lived assets — Europe ($M) [legacy grouping through FY2018] ($M), annual FY2010–FY2018 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/geo_lla_europe_legacy
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.